Corynanthine
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
483-10-3COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1OBLGXFZZNTVWLAY-DKJBZYCGSA-N483-10-3DTXSID401317915CHEBI:92122186 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
184.96 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];171.55 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];182.23 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];181.99 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.
Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS.
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.
説明This alkaloid has been isolated by Hoffmann from the bark of Rauwolfia serpentina. It forms colourless crystals from Me2CO and has [α]20D - 82° (c 0.5, pyridine).
読み込み中…